Biological Industries Business
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue EngineeringMedical Devices
Target Customer
Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnology
Core Technology
BiologicalsCells
Tags (5)
bioprocesscell-therapystem-cellsmolecular-biologypharma-companies
Biological Industries Financials
Biological Industries Lifecycle
Biological Industries News
7 articles
Sartorius Acquires a Majority Stake in Cell Culture Media Specialist Biological Industries
Cromwell life sciences firm inks distribution deal
Cromwells Biological Industries has entered into a distribution partnership with Primorigen, a Wisconsin company, to distribute Primorigens protein matrix for stem cell culture called Vitronectin XF. The financial terms of the deal were not disclosed. This partnership will allow the scientific community to leverage the benefits of Vitronectin XF.
Partners
Biological Industries USA Adds Vitronectin XF™ to its Stem Cell Portfolio Through Agreement with Primorigen Biosciences, Inc.
Biological Industries USA Announces Initial Winners of MSC Research Awards
Biological Industries USA Announces Mesenchymal Stromal and Stem Cell Research Award, Including Conference Travel, Laboratory Reagents, and Potential Publicity for Researchers
Biological Industries USA Signs Agreement With Mill Creek Life Sciences To Add PLTMax Human Platelet Lysate To Its Growing Stem Cell Portfolio - Biological Industries
Biological Industries USA (BI-USA) has announced a distribution agreement with Mill Creek Life Sciences LLC for the distribution of PLTMax® Human Platelet Lysate. This product offers superior growth and cellular properties for the culture of human mesenchymal stem cells. The agreement allows BI-USA to expand its stem cell portfolio reach in the US and beyond. The partnership aims to serve the needs of the stem cell industry through application development. Mill Creek Life Sciences provides tools to support the development and application of cellular and biological therapeutics. The agreement is expected to have a positive impact on the growth of Biological Industries USA.
Partners
Long term agreement between Bartels Stek and Biological Industries (Israel) regarding Gypsophila
Bartels Stek and Biological Industries Ltd (BI) have signed a long-term agreement for the exclusive worldwide distribution of all Gypsophila varieties by Bartels Stek. Bartels Stek will handle worldwide sales, license, and marketing activities for all Gypsophila varieties of BI, except for Israel. The agreement is expected to improve BIs worldwide distribution and benefit growers around the world. Bartels Stek specializes in perennial and fillers, and Gypsophila will be a great addition to their range of filler crops. The teams of BI and Bartels Stek will work closely together to offer customers the best possible service. Testing of all selections will take place in Israel and Kenya.
Partners
Biological Industries Team
Employee Info
| Employees (range) | 51-200 |
| Exact count | 58 |
| Team members | 1 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 10 classification IDs that could be used for matching.
